Show
Sort by
-
- Miscellaneous
- open access
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study (vol 72, pg 475, 2022)
-
- Journal Article
- A1
- open access
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study
-
2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial
(2022) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. In International Journal of Gynecological Cancer 32(Supplement 2). p.A187-A188 -
- Journal Article
- A1
- open access
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients : DAWn-plasma
-
- Journal Article
- A1
- open access
Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo - a post-hoc analysis of the BACE randomized controlled trial
-
Azithromycin during acute chronic obstructive pulmonary disease exacerbations requiring hospitalization (BACE) : a multicenter, randomized, double-blind, placebo-controlled trial
-
Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial : effect on late toxicity and tumor control
-
- Journal Article
- A2
- open access
The CECARI study : everolimus (certican (R)) initiation and calcineurin inhibitor withdrawal in maintenance heart transplant recipients with renal insufficiency : a multicenter, randomized trial
-
Clinical outcome of coronary stenting after thoracic radiotherapy : a case-control study
-
A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the GRACE genetics study